These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21523678)

  • 21. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
    Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
    Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of chronic kidney disease on fibrin clot properties in patients with acute coronary syndrome.
    Undas A; Nycz K; Pastuszczak M; Stompor T; Zmudka K
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):522-7. PubMed ID: 20479639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial.
    James S; Budaj A; Aylward P; Buck KK; Cannon CP; Cornel JH; Harrington RA; Horrow J; Katus H; Keltai M; Lewis BS; Parikh K; Storey RF; Szummer K; Wojdyla D; Wallentin L
    Circulation; 2010 Sep; 122(11):1056-67. PubMed ID: 20805430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Atherosclerosis and rheumatoid arthritis].
    Löwenhoff T; Głuszko P
    Przegl Lek; 2005; 62(12):1506-9. PubMed ID: 16786783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inflammation and plaque instability].
    Malpartida F; Vivancos R; Urbano C; Mora J
    Arch Cardiol Mex; 2007; 77 Suppl 4():S4-16-22. PubMed ID: 18938692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visfatin and endothelial function in dialyzed patients.
    Malyszko J; Malyszko JS; Mysliwiec M
    Nephrology (Carlton); 2010 Mar; 15(2):190-6. PubMed ID: 20470278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal dysfunction and coronary disease: a high-risk combination.
    Schiele F
    J Nephrol; 2009; 22(1):39-45. PubMed ID: 19229817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF; Ma ZG; Mei CL; Rong S; Huang SM; Liu XR; Yuan WJ; Guo YS; Wang L; He Q; Wang XL; Sang XH; Li XL
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(11):753-9. PubMed ID: 15949381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammation.
    Dawood T; Schlaich MP
    Minerva Cardioangiol; 2009 Dec; 57(6):687-704. PubMed ID: 19942842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Causes and consequences of increased arterial stiffness in chronic kidney disease patients.
    Gusbeth-Tatomir P; Covic A
    Kidney Blood Press Res; 2007; 30(2):97-107. PubMed ID: 17374960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability.
    Wasserman EJ; Shipley NM
    Mt Sinai J Med; 2006 Jan; 73(1):431-9. PubMed ID: 16470323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-traditional biomarkers of atherosclerosis in stable and unstable coronary artery disease, do they differ?
    Konstantino Y; Wolk R; Terra SG; Nguyen TT; Fryburg DA
    Acute Card Care; 2007; 9(4):197-206. PubMed ID: 17924231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Atherosclerosis and inflammation: the role of C-reactive protein].
    Ablij HC; Meinders AE
    Ned Tijdschr Geneeskd; 2003 Jan; 147(1):15-20. PubMed ID: 12564292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating.
    Gobal F; Deshmukh A; Shah S; Mehta JL
    J Am Coll Cardiol; 2011 Jun; 57(23):2303-8. PubMed ID: 21636030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.